TABLE OF CONTENTS
Volume 16, Issue 6 (June 2009)
News And Commentary
Gene therapy for cardiomyocytes, a heart beat away FREE
S W J McPhee and R J Samulski
Gene Ther 16: 707-708; advance online publication, April 30, 2009; doi:10.1038/gt.2009.40
Review
Progress and prospects: Biological properties and technological advances of herpes simplex virus type 1-based amplicon vectors
A L Epstein
Gene Ther 16: 709-715; advance online publication, April 16, 2009; doi:10.1038/gt.2009.42
Original Articles
Repeated, but not single, VEGF gene transfer affords protection against ischemic muscle lesions in rabbits with hindlimb ischemia
F D Olea, G Vera Janavel, L Cuniberti, G Yannarelli, P Cabeza Meckert, J Cors, L Valdivieso, G Lev, O Mendiz, A Bercovich, M Criscuolo, C Melo, R Laguens and A Crottogini
Gene Ther 16: 716-723; advance online publication, April 2, 2009; doi:10.1038/gt.2009.30
Indoleamine 2,3-dioxygenase attenuates inhibitor development in gene-therapy-treated hemophilia A mice
L Liu, H Liu, C Mah and B S Fletcher
Gene Ther 16: 724-733; advance online publication, March 5, 2009; doi:10.1038/gt.2009.13
Discrepancies between the fate of myoblast xenograft in mouse leg muscle and NMR label persistency after loading with Gd-DTPA or SPIOs
C Baligand, K Vauchez, M Fiszman, J-T Vilquin and P G Carlier
Gene Ther 16: 734-745; advance online publication, March 12, 2009; doi:10.1038/gt.2009.12
Widespread biochemical correction of murine mucopolysaccharidosis type VII pathology by liver hydrodynamic plasmid delivery
M Richard, A Arfi, J Seguin, C Gandolphe and D Scherman
Gene Ther 16: 746-756; advance online publication, April 9, 2009; doi:10.1038/gt.2009.36
Apolipoprotein A-I and lecithin:cholesterol acyltransferase transfer induce cholesterol unloading in complex atherosclerotic lesions
E Van Craeyveld, J Lievens, F Jacobs, Y Feng, J Snoeys and B De Geest
Gene Ther 16: 757-765; advance online publication, February 26, 2009; doi:10.1038/gt.2009.8
Purification of recombinant baculoviruses for gene therapy using membrane processes
T Vicente, C Peixoto, M J T Carrondo and P M Alves
Gene Ther 16: 766-775; advance online publication, April 2, 2009; doi:10.1038/gt.2009.33
Noncarrier naked antigen-specific DNA vaccine generates potent antigen-specific immunologic responses and antitumor effects
C-A Chen, M-C Chang, W-Z Sun, Y-L Chen, Y-C Chiang, C-Y Hsieh, S M Chen, P-N Hsiao and W-F Cheng
Gene Ther 16: 776-787; advance online publication, April 9, 2009; doi:10.1038/gt.2009.31
High-titer lentiviral vectors stimulate fetal calf serum-specific human CD4 T-cell responses: implications in human gene therapy
L Bao, H Guo, X Huang, S Tammana, M Wong, R S McIvor and X Zhou
Gene Ther 16: 788-795; advance online publication, April 2, 2009; doi:10.1038/gt.2009.34
Genetically engineered Newcastle disease virus for malignant melanoma therapy
D Zamarin, A Vigil, K Kelly, A García-Sastre and Y Fong
Gene Ther 16: 796-804; advance online publication, February 26, 2009; doi:10.1038/gt.2009.14
Development of inducible EIAV-based lentiviral vector packaging and producer cell lines
H J Stewart, M A Leroux-Carlucci, C J M Sion, K A Mitrophanous and P A Radcliffe
Gene Ther 16: 805-814; advance online publication, March 5, 2009; doi:10.1038/gt.2009.20
Short Communications
Real-time monitoring of cell transplantation in mouse dystrophic muscles by a secreted alkaline phosphatase reporter gene
X Gerard, L Vignaud, S Charles, C Pinset, D Scherman, A Kichler and D Israeli
Gene Ther 16: 815-819; advance online publication, March 12, 2009; doi:10.1038/gt.2009.28
In vivo assessment of mutations in OTC for dominant-negative effects following rAAV2/8-mediated gene delivery to the mouse liver
S L Ginn, S C Cunningham, M Zheng, A Spinoulas, K H Carpenter and I E Alexander
Gene Ther 16: 820-823; advance online publication, April 9, 2009; doi:10.1038/gt.2009.38
